Linden Thomas Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
Linden Thomas Advisory Services's EW Position: Q2 2026 in Review
Linden Thomas Advisory Services reduced its Edwards Lifesciences (EW) stake by 0.56% in Q2 2026, selling an estimated $5.28K and leaving 11,130 shares worth $1.01M. The position accounts for 0.08% of the portfolio, ranked #342.
Linden Thomas Advisory Services first reported a position in EW in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.36M in Q2 2023. 374 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Linden Thomas Advisory Services held 11,130 shares of Edwards Lifesciences worth $1.01M as of Q2 2026.
- Linden Thomas Advisory Services sold 63 Edwards Lifesciences shares in Q2 2026, an estimated $5.28K.
- Edwards Lifesciences made up 0.08% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #342 holding.
- Linden Thomas Advisory Services first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 15 quarters since.
- Linden Thomas Advisory Services's Edwards Lifesciences position peaked at $1.36M in Q2 2023.
- 374 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.